These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Site-Directed Chemical Mutations on Abzymes: Large Rate Accelerations in the Catalysis by Exchanging the Functionalized Small Nonprotein Components. Ishikawa F; Shirahashi M; Hayakawa H; Yamaguchi A; Hirokawa T; Tsumuraya T; Fujii I ACS Chem Biol; 2016 Oct; 11(10):2803-2811. PubMed ID: 27552288 [TBL] [Abstract][Full Text] [Related]
23. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies. Ulrich HD; Schultz PG J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442 [TBL] [Abstract][Full Text] [Related]
24. Selective chemotherapeutic strategies using catalytic antibodies: a common pro-moiety for antibody-directed abzyme prodrug therapy. Kakinuma H; Fujii I; Nishi Y J Immunol Methods; 2002 Nov; 269(1-2):269-81. PubMed ID: 12379367 [TBL] [Abstract][Full Text] [Related]
25. Similarities of hydrolytic antibodies revealed by their X-ray structures: a review. Charbonnier JB; Gigant B; Golinelli-Pimpaneau B; Knossow M Biochimie; 1997 Nov; 79(11):653-60. PubMed ID: 9479447 [TBL] [Abstract][Full Text] [Related]
26. Immunological origins of binding and catalysis in a Diels-Alderase antibody. Romesberg FE; Spiller B; Schultz PG; Stevens RC Science; 1998 Mar; 279(5358):1929-33. PubMed ID: 9506942 [TBL] [Abstract][Full Text] [Related]
29. Site-directed mutagenesis of active site contact residues in a hydrolytic abzyme: evidence for an essential histidine involved in transition state stabilization. Miyashita H; Hara T; Tanimura R; Fukuyama S; Cagnon C; Kohara A; Fujii I J Mol Biol; 1997 Apr; 267(5):1247-57. PubMed ID: 9150409 [TBL] [Abstract][Full Text] [Related]
30. Improvement in hydrolytic antibody activity by change in haptenic structure from phosphate to phosphonate with retention of a common leaving-group determinant: evidence for the 'flexibility' hypothesis. Gul S; Sonkaria S; Pinitglang S; Florez-Alvarez J; Hussain S; Thomas EW; Ostler EL; Gallacher G; Resmini M; Brocklehurst K Biochem J; 2003 Dec; 376(Pt 3):813-21. PubMed ID: 12946271 [TBL] [Abstract][Full Text] [Related]
32. Chemical reactivity at an antibody binding site elicited by mechanistic design of a synthetic antigen. Tramontano A; Janda KD; Lerner RA Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6736-40. PubMed ID: 3462723 [TBL] [Abstract][Full Text] [Related]
33. Structural evidence for a programmed general base in the active site of a catalytic antibody. Golinelli-Pimpaneau B; Goncalves O; Dintinger T; Blanchard D; Knossow M; Tellier C Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9892-5. PubMed ID: 10963661 [TBL] [Abstract][Full Text] [Related]
34. A common ancestry for multiple catalytic antibodies generated against a single transition-state analog. Miyashita H; Hara T; Tanimura R; Tanaka F; Kikuchi M; Fujii I Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6045-9. PubMed ID: 8016113 [TBL] [Abstract][Full Text] [Related]
35. Cocaine catalytic antibodies: the primary importance of linker effects. Matsushita M; Hoffman TZ; Ashley JA; Zhou B; Wirsching P; Janda KD Bioorg Med Chem Lett; 2001 Jan; 11(2):87-90. PubMed ID: 11206477 [TBL] [Abstract][Full Text] [Related]
36. Identification of functionally important residues in the pyridoxal-5'-phosphate-dependent catalytic antibody 15A9. Mouratou B; Stetefeld J Biochemistry; 2004 Jun; 43(21):6612-9. PubMed ID: 15157094 [TBL] [Abstract][Full Text] [Related]
37. [Catalytic antibodies: generation of a new class of protein catalysts exploiting the immune system]. Fujii I Yakugaku Zasshi; 1996 Aug; 116(8):606-21. PubMed ID: 8831262 [TBL] [Abstract][Full Text] [Related]
38. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1. 8 A resolution. Kristensen O; Vassylyev DG; Tanaka F; Morikawa K; Fujii I J Mol Biol; 1998 Aug; 281(3):501-11. PubMed ID: 9698565 [TBL] [Abstract][Full Text] [Related]
39. High-resolution crystal structure of the Fab-fragments of a family of mouse catalytic antibodies with esterase activity. Ruzheinikov SN; Muranova TA; Sedelnikova SE; Partridge LJ; Blackburn GM; Murray IA; Kakinuma H; Takahashi-Ando N; Shimazaki K; Sun J; Nishi Y; Rice DW J Mol Biol; 2003 Sep; 332(2):423-35. PubMed ID: 12948492 [TBL] [Abstract][Full Text] [Related]